View Document Preview and Link
Document Date: 2011-10-10 21:06:09 Open Document File Size: 29,54 KB Share Result on Facebook
City Düsseldorf / Pubmed / Czechoslovakia / / Continent Europe / / Country Germany / Switzerland / Hungary / France / Russia / United States / Brazil / China / / Currency USD / / Facility Blood Institute / Heinriche Heine University / / IndustryTerm fewer chemical-synthetic drugs / pharmaceutical biology / treatment for chronic heart failure / heart failure treatment / chemical-synthetic drugs / treatment of patients with congestive heart failure / treatment of patients with heart failure / treatment for those suffering from heart failure / treatment of NYHA stage II heart failure / pressure/heart rate product / chemical / healthcare providers / / MedicalCondition IV heart failure / disease / sudden cardiac death / chronic heart failure / dyspnea / strain / class-III heart failure / shortness of breath / Introduction Heart failure / ventricular extrasystoles / vertigo / II heart failure / Heart Disease / cardiovascular disease / fatigue / Abstract Heart failure / Heart Failure / heart attack / hawthorn heart failure / diseases / dizziness / oxygen deficiency / / MedicalTreatment Phytotherapy / / Organization Statistics Subcommittee / New York Heart Association / Force of Contraction / American Heart Association Statistics Committee / National Heart / Lung / and Blood Institute / Heinriche Heine University / / Person Rudolf Bauer / Rudolf Fritz / Michael Moore / Rudolf Weiss / / Position professor of pharmaceutical biology / / Product amrinone / Digoxin / / Region Southwest / / URL http / SocialTag